影响同时心移植早期不良结果的因素
Bernard John DuBray1, Saed Shawar2, Sandip Zalawadiya3
1Division of Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee.
Transplantation proceedings
|January 21, 2025
概括
移植前透析和较长的冷血缺血时间增加了同时心移植 (SHKT) 的早期不良结果. 在心脏移植后加快脏移植可能会改善结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 移植手术 移植手术
背景情况:
- 同时心脏移植 (SHKTs) 正在增加.
- 对于这些高急性患者的异体移植结果的数据有限.
- 早期不良结果 (EAO),如延迟移植功能 (DGF),初级非功能 (PNF) 和脏全移植无用性 (RAF) 是关键问题.
研究的目的:
- 为了识别与SHKT后的EAO相关的变量.
- 分析影响DGF,PNF和RAF的接收者和操作因素.
- 为了告知改善SHKT结果的策略.
主要方法:
- 成年人SHCT的单中心回顾性审查 (2011年10月 - 2021年8月).
- 用于评估变量和EAO之间的关系的多变量物流回归模型.
- 关键变量包括移植前透析,大动脉内气球,血清乳酸,上腺素使用,重复切骨术和冷血缺血时间 (CIT).
主要成果:
- 进行了68次SHKT;35%经历了DGF,6%的PNF和18%的RAF.
- 移植前透析,血清乳酸和CIT与更高的DGF概率有关.
- 上腺素 (NE) 使用和CIT与RAF的增加有关.
结论:
- 移植前透析是EAO后SHKT的重要风险因素.
- 感冒缺血时间和北上腺素的使用有助于脏全移植的徒劳.
- 加快心脏移植后的移植可能会通过减轻血液动力学和缺血压力来减少EAO.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
376
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
376
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:17Factors Affecting Renal Clearance: Renal Impairment
50
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
50
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:11Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61